Department of Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.
Department of Pharmacology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.
Eur J Pharmacol. 2017 Nov 5;814:255-263. doi: 10.1016/j.ejphar.2017.08.026. Epub 2017 Aug 31.
Statins are well-known inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which block the mevalonate pathway. The activity of statins not only decreases cholesterol levels but also ameliorates inflammation and modulates the immune system. In this study, we investigated the effects of simvastatin on histamine release using rat basophilic leukaemia (RBL-2H3) cells, and examined its interaction with proteins involved in the exocytosis process. Treatment with simvastatin for 24h inhibited histamine release in RBL-2H3 cells in a concentration-dependent manner after stimulation with dinitrophenylated bovine serum albumin (DNP-BSA, as an antigen), ionomycin (a calcium ion [Ca] ionophore), and thapsigargin (an inhibitor of Ca-ATPase in the endoplasmic reticulum). Simvastatin-induced inhibition was counteracted by co-administration of mevalonolactone or geranylgeraniol, but not farnesol. Indeed, several exocytotic proteins were post-translationally modified by isoprenylation, which is required for proper localization in the lipid membrane. RBL-2H3 cells express proteins involved in the fusion of granules and the plasma membrane, such as Ras-like protein in the brain 27a (Rab27a), synaptosome-associated protein 23 (SNAP23), and vesicle-associated membrane protein 7 (VAMP7), as well as Ca binding proteins, such as double C2 alpha (Doc2a), synaptotagmin2, and mammalian uncoordinated13-4 (munc13-4). The interaction of Rab27a and Doc2a proteins was detected using proximity ligation assays. Antigen stimulation caused these proteins to interact, and this interaction could be disrupted by co-administration of simvastatin. In conclusion, simvastatin inhibited the mevalonate pathway, which suppressed the geranylgeranylation of Rab27a by depleting geranylgeranyl pyrophosphate and interfering with the Rab27a-Doc2a interaction. This activity resulted in the inhibition of exocytosis in RBL-2H3 cells.
他汀类药物是众所周知的 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶抑制剂,可阻断甲羟戊酸途径。他汀类药物的活性不仅降低胆固醇水平,还改善炎症和调节免疫系统。在这项研究中,我们使用大鼠嗜碱性白血病(RBL-2H3)细胞研究了辛伐他汀对组氨酸释放的影响,并检查了其与参与胞吐过程的蛋白质的相互作用。用辛伐他汀处理 24 小时后,用二硝基苯甲酰化牛血清白蛋白(DNP-BSA,作为抗原)、离子霉素(钙离子 [Ca]离子载体)和 thapsigargin(内质网中 Ca-ATP 酶抑制剂)刺激后,RBL-2H3 细胞中的组氨酸释放呈浓度依赖性抑制。用甲羟戊酸内酯或香叶基香叶基焦磷酸共处理可拮抗辛伐他汀诱导的抑制,但法呢醇不行。事实上,几种胞吐蛋白通过异戊烯基化进行翻译后修饰,这对于在脂质膜中正确定位是必需的。RBL-2H3 细胞表达与颗粒和质膜融合有关的蛋白质,如脑 27a 中的 Ras 样蛋白 27a(Rab27a)、突触相关蛋白 23(SNAP23)和囊泡相关膜蛋白 7(VAMP7),以及 Ca 结合蛋白,如双 C2a(Doc2a)、突触结合蛋白 2 和哺乳动物协调蛋白 13-4(munc13-4)。使用邻近连接测定法检测 Rab27a 和 Doc2a 蛋白的相互作用。抗原刺激导致这些蛋白质相互作用,而这种相互作用可以通过共给予辛伐他汀来破坏。总之,辛伐他汀抑制了甲羟戊酸途径,通过耗尽香叶基香叶基焦磷酸和干扰 Rab27a-Doc2a 相互作用来抑制 Rab27a 的香叶基香叶基化。这种活性导致 RBL-2H3 细胞胞吐作用的抑制。